MV Capital Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$48.2K Buy
218
+3
+1% +$654 ﹤0.01% 323
2026
Q2
$41.9K Hold
215
– – ﹤0.01% 358
2026
Q1
$48.3K Hold
215
– – ﹤0.01% 326
2025
Q4
$51.8K Hold
215
– – 0.01% 308
2025
Q3
$58.9K Hold
215
– – 0.01% 290
2025
Q2
$55.5K Sell
215
-1
-0.5% -$239 0.01% 290
2025
Q1
$48.4K Buy
216
+1
+0.5% +$233 0.01% 308
2024
Q4
$49.2K Sell
215
-4
-2% -$963 0.01% 294
2024
Q3
$53.5K Buy
219
+1
+0.5% +$223 0.01% 298
2024
Q2
$41.7K Buy
218
+2
+0.9% +$406 ﹤0.01% 312
2024
Q1
$42.8K Buy
216
+2
+0.9% +$366 ﹤0.01% 314
2023
Q4
$36.8K Buy
214
+60
+39% +$9.22K ﹤0.01% 334
2023
Q3
$22.8K Buy
154
+81
+111% +$14.6K ﹤0.01% 372
2023
Q2
$16K Buy
73
+5
+7% +$1.11K ﹤0.01% 444
2023
Q1
$14.9K Buy
68
+11
+19% +$2.39K ﹤0.01% 448
2022
Q4
$11.9K Buy
57
+10
+21% +$2.2K ﹤0.01% 431
2022
Q3
$10K Buy
47
+14
+42% +$3.19K ﹤0.01% 462
2022
Q2
$7K Sell
33
-10
-23% -$2.13K ﹤0.01% 513
2022
Q1
$10K Sell
43
-6
-12% -$1.45K ﹤0.01% 476
2021
Q4
$13K Buy
49
+6
+14% +$1.56K ﹤0.01% 393
2021
Q3
$11K Buy
43
+14
+48% +$3.83K ﹤0.01% 414
2021
Q2
$7K Buy
29
+24
+480% +$5.04K ﹤0.01% 440
2021
Q1
$1K Buy
+5
New +$1K ﹤0.01% 423
2020
Q2
– Sell
-12
Closed -$2K – 345
2020
Q1
$2K Buy
+12
New +$1.91K ﹤0.01% 305

Other funds holding RMD

MV Capital Management's RMD Position: Q3 2026 in Review

MV Capital Management increased its ResMed (RMD) stake by 1.4% in Q3 2026, buying an estimated $654 and bringing the position to 218 shares worth $48.2K. The position accounts for ﹤0.01% of the portfolio, ranked #323.

MV Capital Management first reported a position in RMD in Q1 2020 and has held it in 24 quarters since. The position peaked at $58.9K in Q3 2025. 480 funds tracked by Wall St. Rank hold RMD as of Q3 2026.

  • MV Capital Management held 218 shares of ResMed worth $48.2K as of Q3 2026.
  • MV Capital Management bought 3 ResMed shares in Q3 2026, an estimated $654.
  • ResMed made up ﹤0.01% of MV Capital Management's portfolio in Q3 2026, its #323 holding.
  • MV Capital Management first reported a position in ResMed in Q1 2020 and has held it in 24 quarters since.
  • MV Capital Management's ResMed position peaked at $58.9K in Q3 2025.
  • 480 funds tracked by Wall St. Rank held ResMed as of Q3 2026.

Based on MV Capital Management's 13F filing for Q3 2026, filed 29 Oct 2026.